Australian Competition and Consumer Commission v Baxter Healthcare Pty Ltd

In the Federal Court of Australia, the Australian Competition and Consumer Commission (ACCC) brought a case against Baxter Healthcare Pty Ltd, alleging breaches of consumer law in relation to contracts with State Purchasing Authorities (SPAs). Baxter, a subsidiary of Baxter International Inc, had entered into long-term contracts with various state and territory authorities for the supply of sterile fluids and peritoneal dialysis solutions between 1998 and 2001. The ACCC claimed that Baxter engaged in anti-competitive conduct by entering into exclusive contracts that stifled competition and led to higher prices for consumers.

The primary legal issue before the court was whether Baxter's conduct constituted a breach of section 45 of the Competition and Consumer Act 2010 (Cth), which prohibits anti-competitive agreements. The court had to assess whether Baxter’s actions in securing exclusive contracts with the SPAs were designed to eliminate or substantially lessen competition in the relevant markets, thus harming consumers through inflated prices or reduced product quality.

In determining the matter, the court examined the nature and terms of the contracts and Baxter's market position. It considered whether Baxter's actions were reasonable and necessary for the protection of its business or whether they were intended to exclude competitors from the market. The court concluded that Baxter’s conduct did not contravene section 45 of the Competition and Consumer Act, finding that Baxter had not engaged in anti-competitive practices. The court noted that the contracts were necessary for Baxter to secure the financial viability of its operations and that there was no evidence of anti-competitive intent or effect. Consequently, the court dismissed the ACCC's application and determined that the reasons for judgment previously published on 16 May 2005 could no longer be considered confidential.